Diabetic Foot
304
32
50
156
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
22 trials with published results (7%)
Research Maturity
156 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.6%
20 terminated out of 304 trials
88.6%
+2.1% vs benchmark
9%
28 trials in Phase 3/4
14%
22 of 156 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 156 completed trials
Clinical Trials (304)
Effectiveness of Remote Foot Temperature Monitoring
WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
Ultrasonic Enhancement Delivery of Phosphodiesterase Inhibitors Nanoparticles for Diabetic Management of the Foot
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
Extracorporeal Shockwave Therapy for Diabetic Foot Ulcers
3D Printed vs Ready-to-Wear Insoles for Diabetic Neuropathy
Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections
Effectiveness of a Structured Educational Program on Pain Intensity, Self-Efficacy, Foot Self-Care Behaviors, and Health-Related Quality of Life Among Adults With Diabetic Foot
Dose-finding Study: Popliteal Sciatic Nerve Block in Patients Undergoing Diabetic Foot Surgery
Hemodynamic Effects of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
Stromal Vascular Cells for the Treatment of Diabetic Peripheral Neuropathy
Crossing the Divide: Piloting Integrated Care to Reduce Amputations Among Rural Patients With Diabetic Foot Ulcers
Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain
Platelet Rich Plasma VS Platelet Fibrin Plasma in Treatment of Diabetes Related Wound：a Randomized Controlled Trial
CGM and DFU Healing Post-discharge
Inforatio Technique to Promote Wound Healing of Diabetic Foot Ulcers
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia
Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus